Choosing the best surgery for rectal cancer
Part of Cancer, Digestive system clinical trials.
This trial compares surgical techniques for removing rectal cancer (anterior resection). It looks at patients with adenocarcinoma who are scheduled for surgery to find the best approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a type of surgery called 'anterior resection' to remove the part of your rectum with cancer.
- You are 18 years or older.
- Your tumor type is adenocarcinoma (the most common kind of rectal cancer).
- Your cancer stage is T1, T2, T3, or T4a (it has not spread to nearby organs or bones).
- Your surgery aims to remove all visible cancer (R0 resection).
- You have not had any previous rectal surgery, and there is no other tumor in your colon at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of minimally invasive surgery (robotic-assisted and laparoscopic) for middle and low rectal cancer. The goal is to see which approach offers better outcomes for patients who qualify.
This study tests a specific “before surgery” treatment (radiation plus chemotherapy), followed by more chemotherapy to improve outcomes in people with certain types of rectal cancer. You might be considered if your cancer is locally advanced but not spread to distant organs.
This trial compares different surgical approaches for women with rectal cancer who are scheduled for a specific type of laparoscopic surgery. It aims to find which approach works best.
This trial compares two different surgery approaches for early-stage rectal cancer (T2N0M0) that is close to the anus. It tests whether a less invasive local removal followed by radiation works as well as more extensive surgery (total mesorectal excision).
This trial compares two approaches for low-risk locally advanced rectal cancer: going straight to surgery (TME) versus receiving chemotherapy before surgery. The goal is to see if upfront surgery works just as well, sparing patients from chemotherapy side effects.
This trial tests whether a full course of chemotherapy and radiation before any surgery (called total neoadjuvant therapy) can help you avoid surgery and preserve your rectum. It is for people with a specific early stage of rectal cancer that has not spread.
Hear when a new Rectal Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.